Close Menu
Home » Guardant Health Q4 Revenues Up 64 Percent

Guardant Health Q4 Revenues Up 64 Percent

Mar 12, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Guardant Health's stock surged in Wednesday morning trading after the company reported that its fourth quarter revenues rose 64 percent year over year, driven by a 98 percent increase in revenues from its precision oncology business.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

PLOS Papers on Prostate Cancer by Ancestry, Korean Liver Function Genetics, Vibrio Cholerae

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

Genomics for Viral Tracking

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

Even More Personalized Medicines

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

Plan for Alzheimer's

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.

What's Popular?

In Business News

  1. Karius Raises $165M in Series B Financing Round

  2. GenapSys to Offer Twist Bioscience Library Prep, Target Enrichment Products

  3. Illumina Seeks Preliminary Injunction Against BGI in US Patent Infringement Case

  4. Swift Biosciences, LGC BioSearch Partner on Targeted Sequencing for Ag-Bio

  5. 10x Genomics Previews New Product Lineup Ahead of AGBT

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.